Brochure | May 12, 2021

Enabling Technology Platform: Patient-Centric Therapeutics

Source: Celanese

VitalDose® EVA is a copolymer drug-delivery platform providing controlled release through implant and insert dosage forms. Whether the challenge relates to a new molecular entity and new target, or an opportunity in the life cycle management, our scientists and engineers will partner with you to create novel drug-products.

  • Biologics and small molecules
  • High drug loading capacity
  • Variety of geometries
  • Local or systemic administration
  • Long clinical use history
  • Established regulatory path

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online